DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer

Por Drouillard, A, Puleo, F, Bachet, J B, Ouazzani, S, Calomme, A, Demetter, P, Verset, G, Van Laethem, J L, Maréchal, R
Publicado no Br J Cancer (2016)

Prognosis and predictive value of KIT exon 11 deletion in GISTs

Por Bachet, J-B, Hostein, I, Le Cesne, A, Brahimi, S, Beauchet, A, Tabone-Eglinger, S, Subra, F, Bui, B, Duffaud, F, Terrier, P, Coindre, J-M, Blay, J-Y, Emile, J-F
Publicado em 2009

Colorectal cancer (CRC) monitoring by 6-monthly (18)FDG-PET/CT: an open-label multicentre randomised trial

Por Sobhani, I, Itti, E, Luciani, A, Baumgaertner, I, Layese, R, André, T, Ducreux, M, Gornet, J -M, Goujon, G, Aparicio, T, Taieb, J, Bachet, J -B, Hemery, F, Retbi, A, Mons, M, Flicoteaux, R, Rhein, B, Baron, S, Cherrak, I, Rufat, P, Le Corvoisier, P, de’Angelis, N, Natella, P -A, Maoulida, H, Tournigand, C, Durand Zaleski, I, Bastuji-Garin, S
Publicado no Ann Oncol (2018)